FGEN icon

FibroGen

225 hedge funds and large institutions have $3.15B invested in FibroGen in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 77 increasing their positions, 72 reducing their positions, and 16 closing their positions.

Holders
225
Holders Change
+22
Holders Change %
+10.84%
% of All Funds
4.88%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
38
Increased
77
Reduced
72
Closed
16
Calls
$43.5M
Puts
$175M
Net Calls
-$132M
Net Calls Change
-$163M
Name Market Value Shares Shares
Change
Shares
Change %
D.E. Shaw & Co
226
D.E. Shaw & Co
New York
-163,677 Closed
Marshall Wace
227
Marshall Wace
United Kingdom
-123,947 Closed
SSA
228
Schonfeld Strategic Advisors
New York
-71,300 Closed
Squarepoint
229
Squarepoint
New York
-51,663 Closed
MWNA
230
Marshall Wace North America
New York
-37,362 Closed
NICM
231
Neo Ivy Capital Management
New York
-17,611 Closed
UR
232
USCA RIA
Texas
-13,333 Closed
AI
233
Atom Investors
Texas
-10,156 Closed
DC
234
Diametric Capital
Massachusetts
-8,966 Closed
EMG
235
Ellington Management Group
Connecticut
-8,800 Closed
PCM
236
Prelude Capital Management
New York
-4,172 Closed
JA
237
JOYN Advisors
Georgia
-2,554 Closed
AIC
238
Ameritas Investment Company
Nebraska
-2,300 Closed
GT
239
Glenmede Trust
Pennsylvania
-235 Closed
CI
240
CX Institutional
Indiana
-100 Closed
IA
241
IFP Advisors
Florida
-6 -100%
GPP
242
Great Point Partners
Connecticut
BFM
243
Boothbay Fund Management
New York
Simplex Trading
244
Simplex Trading
Illinois
HT
245
HAP Trading
New York
KCM
246
Kingdon Capital Management
New York
Balyasny Asset Management
247
Balyasny Asset Management
Illinois